<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04986943</url>
  </required_header>
  <id_info>
    <org_study_id>08-20-01A</org_study_id>
    <nct_id>NCT04986943</nct_id>
  </id_info>
  <brief_title>ABTHERA ADVANCE™ Use Without Wittman Patch</brief_title>
  <official_title>Use of the ABTHERA ADVANCE™ Open Abdomen Dressing in Patients With Necrotizing Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Atrium Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients&#xD;
      requiring open abdomen due to necrotizing pancreatitis. The institutions traditional approach&#xD;
      is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE&#xD;
      has shown in vitro to have improved tension on the abdominal wall that may obviate the need&#xD;
      for costly Wittmann patch placement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients&#xD;
      requiring open abdomen due to necrotizing pancreatitis. The instiutions traditional approach&#xD;
      is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE&#xD;
      has shown in vivotro to have improved fascia movement that may obviate the need for costly&#xD;
      Wittmann patch placement.&#xD;
&#xD;
      Primary Objective: Determine the variable cost savings associated with use of ABTHERA&#xD;
      ADVANCE™ without the use of Wittmann patch Hypothesis: The hypothesis is that with use of the&#xD;
      ABTHERA ADVANCE will lead to reduced variable costs compared to ABTHERA Open Abdomen dressing&#xD;
      with Wittmann patch Secondary Objective(s): Determine the rate of abdominal closure,&#xD;
      component separation, and mesh placement with the ABTHERA ADVANCE™ without the use of&#xD;
      Wittmann patch Hypothesis: The hypothesis is that rate of abdominal closure, component&#xD;
      separation, and mesh placement will appear similar with use of ABTHERA ADVANCE compared to&#xD;
      ABTHERA Open Abdomen dressing with Wittmann patch&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 12, 2020</start_date>
  <completion_date type="Anticipated">December 21, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 21, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cost Saving</measure>
    <time_frame>3 months after the last participant has been enrolled.</time_frame>
    <description>Determine the variable cost savings associated with use of ABTHERA ADVANCE™ without the use of Wittmann patch.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>3 months after the last participant has been enrolled.</time_frame>
    <description>Determine the rate of abdominal closure, component separation, and mesh placement with the ABTHERA ADVANCE™ without the use of Wittmann patch.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Necrotizing Pancreatitis</condition>
  <arm_group>
    <arm_group_label>ABTHERA Advance without Wittmann patch</arm_group_label>
    <description>Patients with necrotizing pancreatitis that require an open abdomen after their initial operation will be treated with ABTHERA ADVANCE only, without the use of Wittmann patch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Using ABTHERA Advance without a Wittmann Patch</intervention_name>
    <description>In this group, patients will be receiving only the ABTHERA Advance product, without the use of the Wittmann Patch</description>
    <arm_group_label>ABTHERA Advance without Wittmann patch</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The target study population is patients with necrotizing pancreatitis that require an open&#xD;
        abdomen. Pancreatitis is a wide spectrum of disease, however patients with necrotizing&#xD;
        pancreatitis are a relatively small subset. As a quaternary care center for patients with&#xD;
        pancreatic diseases, most patients in Atrium's care network with severe necrotizing&#xD;
        pancreatitis are referred to Carolinas Medical Center. The patients that will be approached&#xD;
        for this study are those in the intensive care unit that develop abdominal compartment&#xD;
        syndrome or severe pancreatitis requiring laparotomy. The goal for patient enrollment will&#xD;
        be 20 patients and outcomes for these patients will be compared to a historical cohort of&#xD;
        40 patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or Female patients aged ≥ 22&#xD;
&#xD;
          -  Severe necrotizing pancreatitis with abdominal compartment syndrome or severe sepsis&#xD;
             requiring decompressive laparotomy and/or pancreatic debridement&#xD;
&#xD;
          -  Patients that require open abdomen at the conclusion of their index operation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Female patients who are pregnant or lactating&#xD;
&#xD;
          -  If in the opinion of the treating physician a patient should not participate in this&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Dionisios Vrochides, MD, PhD</last_name>
    <phone>704-355-1813</phone>
    <email>dionisios.vrochides@atriumhealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katheryn M Peterson, BS</last_name>
    <phone>704-446-4838</phone>
    <email>katheryn.peterson@atriumhealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Atrium Health</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dionisios Vrochides, MD, PhD</last_name>
      <phone>704-355-1813</phone>
      <email>dionisios.vrochides@atriumhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Katheryn M Peterson, BSPH</last_name>
      <phone>704-446-4838</phone>
      <email>katheryn.peterson@atriumhealth.ord</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Plaudis H, Rudzats A, Melberga L, Kazaka I, Suba O, Pupelis G. Abdominal negative-pressure therapy: a new method in countering abdominal compartment and peritonitis - prospective study and critical review of literature. Ann Intensive Care. 2012 Dec 20;2 Suppl 1:S23. doi: 10.1186/2110-5820-2-S1-S23. Epub 2012 Dec 20.</citation>
    <PMID>23281649</PMID>
  </reference>
  <reference>
    <citation>Turza KC, Campbell CA, Rosenberger LH, Politano AD, Davies SW, Riccio LM, Sawyer RG. Options for closure of the infected abdomen. Surg Infect (Larchmt). 2012 Dec;13(6):343-51. doi: 10.1089/sur.2012.014. Epub 2012 Dec 10. Review.</citation>
    <PMID>23216525</PMID>
  </reference>
  <reference>
    <citation>García-Corral JR, Cárdenas-Lailson LE, Sanjuan-Martínez CA, Arellano-Solorio CH, Aquino-Matus JE, Carrillo-Romero A. Negative pressure therapy in combination with mesh-mediated fascial traction in the treatment of infected pancreatic necrosis. A new therapeutic option. Cir Cir. 2019;87(2):219-223. doi: 10.24875/CIRU.18000472.</citation>
    <PMID>30768066</PMID>
  </reference>
  <reference>
    <citation>Sermoneta D, Di Mugno M, Spada PL, Lodoli C, Carvelli ME, Magalini SC, Cavicchioni C, Bocci MG, Martorelli F, Brizi MG, Gui D. Intra-abdominal vacuum-assisted closure (VAC) after necrosectomy for acute necrotising pancreatitis: preliminary experience. Int Wound J. 2010 Dec;7(6):525-30. doi: 10.1111/j.1742-481X.2010.00727.x. Epub 2010 Aug 19.</citation>
    <PMID>20726923</PMID>
  </reference>
  <reference>
    <citation>Jensen RO, Buchbjerg T, Simonsen RM, Eckardt R, Qvist N. Vacuum-Assisted Abdominal Closure Is Safe and Effective: A Cohort Study in 74 Consecutive Patients. Surg Res Pract. 2017;2017:7845963. doi: 10.1155/2017/7845963. Epub 2017 Sep 11.</citation>
    <PMID>29085880</PMID>
  </reference>
  <reference>
    <citation>Kubiak BD, Albert SP, Gatto LA, Snyder KP, Maier KG, Vieau CJ, Roy S, Nieman GF. Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis and ischemia/reperfusion model. Shock. 2010 Nov;34(5):525-34. doi: 10.1097/SHK.0b013e3181e14cd2.</citation>
    <PMID>20823698</PMID>
  </reference>
  <reference>
    <citation>Kirkpatrick AW, Roberts DJ, Faris PD, Ball CG, Kubes P, Tiruta C, Xiao Z, Holodinsky JK, McBeth PB, Doig CJ, Jenne CN. Active Negative Pressure Peritoneal Therapy After Abbreviated Laparotomy: The Intraperitoneal Vacuum Randomized Controlled Trial. Ann Surg. 2015 Jul;262(1):38-46. doi: 10.1097/SLA.0000000000001095.</citation>
    <PMID>25536308</PMID>
  </reference>
  <reference>
    <citation>Frazee RC, Abernathy SW, Jupiter DC, Hendricks JC, Davis M, Regner JL, Isbell T, Smith RW, Smythe WR. Are commercial negative pressure systems worth the cost in open abdomen management? J Am Coll Surg. 2013 Apr;216(4):730-3; discussion 733-5. doi: 10.1016/j.jamcollsurg.2012.12.035. Epub 2013 Feb 13.</citation>
    <PMID>23415556</PMID>
  </reference>
  <reference>
    <citation>Olona C, Caro A, Duque E, Moreno F, Vadillo J, Rueda JC, Vicente V. Comparative study of open abdomen treatment: ABThera™ vs. abdominal dressing™. Hernia. 2015 Apr;19(2):323-8. doi: 10.1007/s10029-014-1253-5. Epub 2014 Apr 23.</citation>
    <PMID>24756917</PMID>
  </reference>
  <reference>
    <citation>Cheatham ML, Demetriades D, Fabian TC, Kaplan MJ, Miles WS, Schreiber MA, Holcomb JB, Bochicchio G, Sarani B, Rotondo MF. Prospective study examining clinical outcomes associated with a negative pressure wound therapy system and Barker's vacuum packing technique. World J Surg. 2013 Sep;37(9):2018-30. doi: 10.1007/s00268-013-2080-z.</citation>
    <PMID>23674252</PMID>
  </reference>
  <reference>
    <citation>Wittmann DH, Aprahamian C, Bergstein JM, Edmiston CE, Frantzides CT, Quebbeman EJ, Condon RE. A burr-like device to facilitate temporary abdominal closure in planned multiple laparotomies. Eur J Surg. 1993 Feb;159(2):75-9.</citation>
    <PMID>8098630</PMID>
  </reference>
  <reference>
    <citation>Bruhin A, Ferreira F, Chariker M, Smith J, Runkel N. Systematic review and evidence based recommendations for the use of negative pressure wound therapy in the open abdomen. Int J Surg. 2014 Oct;12(10):1105-14. doi: 10.1016/j.ijsu.2014.08.396. Epub 2014 Aug 28. Review.</citation>
    <PMID>25174789</PMID>
  </reference>
  <reference>
    <citation>Quyn AJ, Johnston C, Hall D, Chambers A, Arapova N, Ogston S, Amin AI. The open abdomen and temporary abdominal closure systems--historical evolution and systematic review. Colorectal Dis. 2012 Aug;14(8):e429-38. doi: 10.1111/j.1463-1318.2012.03045.x. Review.</citation>
    <PMID>22487141</PMID>
  </reference>
  <reference>
    <citation>Atema JJ, Gans SL, Boermeester MA. Systematic review and meta-analysis of the open abdomen and temporary abdominal closure techniques in non-trauma patients. World J Surg. 2015 Apr;39(4):912-25. doi: 10.1007/s00268-014-2883-6. Review.</citation>
    <PMID>25446477</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atrium Health</investigator_affiliation>
    <investigator_full_name>Dionisios Vrochides</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Abdominal compartment syndrome</keyword>
  <keyword>Necrotizing Pancreatitis</keyword>
  <keyword>Severe sepsis</keyword>
  <keyword>Necrotizing Pancreatitis with abdominal compartment syndrome</keyword>
  <keyword>Necrotizing Pancreatitis with severe sepsis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Acute Necrotizing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

